PTK2 and cancer: Regarding the contribution of FAK to the acquisition of cancer stem cell (CSC) attributes, Fan et al. [161] were able to show that increased FAK expression caused by promotor hypomethylation led to the expression of stem cell markers in liver carcinoma cell lines.